Primary prevention with low dose aspirin cuts cardiovascular deathsBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7279.128 (Published 20 January 2001) Cite this as: BMJ 2001;322:128
- Susan Mayor
Low dose aspirin significantly reduces the risk of cardiovascular events and deaths in people with at least one risk factor but no history of cardiovascular disease, according to a major primary prevention study published last week.
The study of 4495 people recruited in general practices throughout Italy showed that low dose aspirin (100 mg a day) reduced the risk of cardiovascular death by 44% at 3.6 years of follow up (Lancet 2001;357:89-95).
The proportion of participants dying from cardiovascular causes was 1.4% in those not receiving aspirin and 0.8% in those taking aspirin. The corresponding …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial